#RIXCoLtd

Resolved to dispose treasury stock. 6,626 shares to be disposed at 3,500 yen per share for a total of 23,191,000 yen allocated to recipients as in-kind contributions. The restricted period starts on 2026-08-05 and continues until retirement date, with release conditions such as continued attendance at the ordinary general meeting.

Our company obtained regulatory approval in 2021 and submitted the approval clearance document for PureLift, which was reimbursed in 2022, but the approval has since expired. Domestic supply has been discontinued, and delays in establishing a new manufacturing system have occurred. Meanwhile, development of endoscopic mucosal injection materials based on self-assembled peptide technology is being promoted for the U.S. market....